newsfilter
← Latest News
FDA Approved Drugs·

Approval of Terlivaz, Nda #022231 (Type 1 - New Molecular Entity)

Approval Date: 09/14/2022; Drug Name: Terlivaz, Nda #022231; Active Ingredients: TERLIPRESSIN; Company: Mallinckrodt; Submission Status: Approval; Submission Classification: Type 1 - New Molecular Entity; Application Number: 022231

Company
MALLINCKRODT
Keywords
MALLINCKRODT